Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
BMC Infectious Diseases|April 17, 2020
Detection of viral RNA in diverse body fluids in an SFTS patient with encephalopathy, gastrointestinal bleeding and pneumonia: a case report and literature reviewKazumasa Akagi, Taiga Miyazaki, Kazuhiro Oshima, et al.
Influenza and Other Respiratory Viruses|August 9, 2011
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 28, 2024
Pre-clinical and clinical evaluation of a surface plasmon field-enhanced fluorescence spectroscopy (SPFS) antigen test for detecting SARS-CoV-2Nobuyuki Ashizawa, Takahiro Takazono, Kenji Ota, et al.
Mycoses|October 8, 2025
Evaluating the Potential of Galactosaminogalactan as a Diagnostic Target for Invasive AspergillosisTakahiro Takazono, Kiyotaka Machida, Francois Le Mauff, et al.
Microbiology Spectrum|March 24, 2026
Non-viable <i>Aspergillus fumigatus</i> promotes chronic inflammation and angiogenesis in a murine fungus ball modelRyosuke Hamashima, Masato Tashiro, Yuichiro Nakano, et al.
Vaccine|March 4, 2014
WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013Ian G Barr, Colin Russell, Terry G Besselaar, et al.
Antiviral Research|July 22, 2014
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013Adam Meijer, Helena Rebelo-de-Andrade, Vanessa Correia, et al.
The Lancet. Infectious Diseases|December 1, 2024
Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysisAbhinav Sengupta, Animesh Ray, Ashish Datt Upadhyay, et al.
Antiviral Research|June 7, 2016
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015Aeron C Hurt, Terry G Besselaar, Rod S Daniels, et al.
Therapeutic Advances in Infectious Disease|March 26, 2026
Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study)Kazuko Yamamoto, Naoki Iwanaga, Asuka Umemura, et al.
Pageof 26